Related Experiment Videos

[Gestational diabetes--perinatal hyperinsulinism and postnatal developmental disorders]

V Briese1, H Stiete, S Stiete

  • 1Frauenklinik, Universität Rostock, Ernst-Moritz-Arndt-Universität Greifswald.

Zentralblatt Fur Gynakologie
|January 1, 1997
PubMed

Insights

Impaired glucose tolerance in pregnancy (IGT) impacts fetal health and long-term risks for diabetes and obesity. Early glucose screening in pregnancy is crucial for monitoring maternal glycemia and improving neonatal outcomes.

Area of Science:

  • Endocrinology
  • Maternal-Fetal Medicine
  • Public Health

Background:

  • Impaired glucose tolerance in pregnancy (IGT) is linked to fetal hyperinsulinism, increasing risks for insulin-dependent diabetes mellitus (IDDM), non-insulin-dependent diabetes (NIDDM), obesity, and cardiovascular diseases.
  • Prospective studies on newborns of diabetic mothers are challenging due to fragmented healthcare management.
  • Current preventive strategies often overlook the importance of gestational diabetes screening for reducing long-term morbidity.

Purpose of the Study:

  • To advocate for universal glucose screening during pregnancy.
  • To investigate the long-term developmental outcomes of newborns.
  • To emphasize the role of maternal glycemic control in preventing future health issues.

Main Methods:

  • Review of existing literature on impaired glucose tolerance in pregnancy and its long-term effects.
  • Analysis of the relationship between maternal glycemia and neonatal health.
  • Evaluation of the impact of glycosylated hemoglobin and amniotic fluid insulin levels.

Main Results:

  • Maternal hyperglycemia during pregnancy is a significant determinant of neonatal health and later-life morbidity.
  • The quality of maternal glycemic control, assessed via HbA1c and amniotic fluid insulin, influences neonatal outcomes.
  • Lack of comprehensive gestational diabetes screening limits preventive potential.

Conclusions:

  • Implementing general glucose screening in pregnancy is essential for early detection and management of IGT.
  • Improved maternal glycemic control can mitigate neonatal risks and reduce the incidence of future metabolic and cardiovascular diseases.
  • Proactive screening and management are vital for decreasing the morbidity associated with diabetes and obesity in offspring.

Related Concept Videos